CELEX: 62010CN0422
Language: en
Date: 2010-08-27 00:00:00
Title: Case C-422/10: Reference for a preliminary ruling from High Court of Justice (Chancery Division) (United Kingdom) made on 27 August 2010 — Georgetown University, University of Rochester, Loyola University of Chicago v Comptroller-General of Patents, Designs and Trade Marks

6.11.2010   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 301/12
            
         Reference for a preliminary ruling from High Court of Justice (Chancery Division) (United Kingdom) made on 27 August 2010 — Georgetown University, University of Rochester, Loyola University of Chicago v Comptroller-General of Patents, Designs and Trade Marks
   (Case C-422/10)
   ()
   2010/C 301/17
   Language of the case: English
   
      Referring court
   
   High Court of Justice (Chancery Division)
   
      Parties to the main proceedings
   
   
      Applicants: Georgetown University, University of Rochester, Loyola University of Chicago
   
      Defendant: Comptroller-General of Patents, Designs and Trade Marks
   
      Question referred
   
   
               1.
            
            
               Does the SPC Regulation and, in particular, Article 3(b), permit the grant of a Supplementary Protection Certificate for a single active ingredient or combination of active ingredients where:
               
                           (a)
                        
                        
                           a basic patent in force protects the single active ingredient or combination of active ingredients within the meaning of Article 3(a) of the SPC Regulation; and
                        
                     
                           (b)
                        
                        
                           a medicinal product containing the single active ingredient or combination of active ingredients together with one or more other active ingredients is the subject of a valid authorisation granted in accordance with Directive 2001/83/EC (1) or 2001/82/EC (2) which is the first marketing authorization that places the single active ingredient or combination of active ingredients on the market?
                        
                     
         
      (1)  Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
   OJ L 311, p. 67
   
      (2)  Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products
   OJ L 311, p. 1